- $2.06m
- -$2.36m
- $1.93m
iSpecimen Inc expected to post a loss of 32 cents a share - Earnings Preview
iSpecimen Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: iSpecimen Expands Biospecimen Provider Network
Brief: iSpecimen Names Tracy Curley As CEO
Brief: iSpecimen Appoints Joseph Basile To Board Of Directors
iSpecimen Inc reports results for the quarter ended in September - Earnings Summary
Brief: Ispecimen Reports Third Quarter Financial And Operating Results
iSpecimen Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: iSpecimen Names Chief Financial Officer, Tracy Curley, Interim CEO
U.S. RESEARCH ROUNDUP-Enovix, IRhythm Technologies, Paramount Global
Brief: iSpecimen Q2 Loss Per Share Of $0.30
Brief: iSpecimen Inc Files For Offering Of Up To 2.6 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
ISpecimen adds new suppliers to marketplace platform; Shares rise
Brief: iSpecimen Files For Mixed Shelf Of Up To $100 Million
Brief: Ispecimen Appoints Evan Cox As Vice President Of Product Management
Brief: Ispecimen Adds Acutis Diagnostics To Marketplace Platform To Support Oncology And Infectious Disease Research
iSpecimen Inc expected to post a loss of 22 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:51 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM